Adult-onset asthma is asthma that first appears at age 18 or older, and it accounts for the majority of new asthma diagnoses. A Finnish population study found that roughly 64% of people with physician-diagnosed asthma received their diagnosis in adulthood rather than childhood.1Respiratory Medicine. Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood Despite that prevalence, adult-onset asthma remains under-recognized partly because many people and even some clinicians still think of asthma as a childhood disease you either outgrow or never get. The adult version tends to behave differently from childhood asthma in ways that affect diagnosis, treatment, and long-term outlook.
How Common It Is and Who Gets It
New cases of asthma keep appearing well into middle age and beyond. In a large Swiss cohort followed for 20 years, about 6.4% of adults developed doctor-diagnosed asthma during the follow-up period.2European Respiratory Journal. Gender differences in adult-onset asthma: results from the Swiss SAPALDIA cohort study The condition is not rare, and the incidence does not trail off with age as sharply as many people assume.
Women are disproportionately affected. In the Swiss cohort, women were about twice as likely as men to develop new asthma in adulthood.3European Respiratory Journal. Gender differences in adult-onset asthma: results from the Swiss SAPALDIA cohort study The Finnish data tell a similar story: women were diagnosed with adult-onset asthma more often than men, with nearly 68% of women receiving their asthma diagnosis after age 18 compared with about 58% of men.4Respiratory Medicine. Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood That female predominance stands in contrast to childhood asthma, where boys are diagnosed more frequently. The reasons are not fully settled, but hormonal factors appear to play a role, which comes up repeatedly in the research on menopause and hormone therapy.
How Adult-Onset Asthma Differs From Childhood Asthma
Asthma that begins in adulthood is a different animal from the classic childhood version in several important ways. Childhood asthma is usually allergic in nature, driven by sensitivity to things like dust mites, pet dander, or pollen. Adult-onset asthma is often non-allergic, meaning standard allergy tests may come back negative even though the person clearly has asthma symptoms.5PubMed Central. Adult-onset asthma: is it really different? This distinction matters for treatment, because therapies targeting allergic pathways work best in people whose asthma is actually driven by allergies.
Research from western Sweden confirmed that allergic asthma becomes less common as people age, so among older adults who develop asthma, non-allergic forms dominate.6PubMed Central. Lifetime asthma incidence is related to age at onset and allergies in western Sweden Allergic sensitization still matters for some adults. In the Swiss cohort, having allergies roughly tripled the overall risk of developing asthma, and in men specifically, allergic sensitization increased the risk nearly fivefold.7European Respiratory Journal. Gender differences in adult-onset asthma: results from the Swiss SAPALDIA cohort study But among adults without allergies, women were more than three times as likely as men to develop asthma, suggesting that non-allergic pathways play a particularly large role in women’s adult-onset disease.
Adult-onset asthma also tends to be more severe from the start, and lung function declines faster than in people whose asthma began in childhood.8PubMed Central. Adult-onset asthma: is it really different? One study tracking adult asthmatics over ten years found that lung function dropped by roughly 42 mL per year during the first five years, slowing somewhat to about 26 mL per year in the second five years.9PubMed Central. Lung Function Decline in Adult Asthmatics—A 10-Year Follow-Up Retrospective and Prospective Study For context, healthy adults lose about 20–30 mL per year simply from aging, so uncontrolled adult asthma can significantly accelerate that decline.
The Inflammatory Subtypes That Shape Treatment
Not all adult-onset asthma looks the same under the microscope. When researchers sort patients by the types of white blood cells driving their airway inflammation, distinct patterns emerge. A study that grouped adult-onset asthma patients by blood cell profiles found four categories: a majority had neither elevated eosinophils nor elevated neutrophils (paucigranulocytic), while smaller groups had predominantly eosinophilic, predominantly neutrophilic, or mixed inflammation.10PubMed. Association Between Blood Eosinophils and Neutrophils With Clinical Features in Adult-Onset Asthma The eosinophilic group tended to have nasal polyps, sinus disease, and markers of allergic-type inflammation. The neutrophilic group showed a different profile, with markers of systemic inflammation more commonly associated with infections or obesity.
This distinction has real consequences for treatment. Standard inhaled corticosteroids work well against eosinophilic inflammation, but non-eosinophilic asthma responds poorly to them. Non-eosinophilic forms may account for about half of severe asthma cases, which helps explain why so many adults with asthma struggle to get their symptoms under control with conventional inhalers alone.11PubMed Central. Non-eosinophilic asthma: current perspectives. A population-based study of adult-onset asthma found that non-allergic features like obesity and higher blood neutrophils were the factors most strongly linked to poor asthma control and the need for higher doses of inhaled corticosteroids.12Respiratory Medicine. Clinical characteristics, asthma control and treatment in adult-onset asthma: A population-based study
Obesity, Hormones, Stress, and Other Risk Factors
Obesity is one of the strongest and most consistent risk factors for developing asthma as an adult, and it also makes existing asthma harder to control. The relationship goes beyond simply being out of shape and feeling winded. Excess body fat drives low-grade systemic inflammation that can inflame the airways independently of allergies. Obesity-associated asthma has become recognized as its own phenotype, one that is predominantly non-allergic, female-predominant, and tends to respond poorly to standard treatment.13PubMed Central. Obesity, Inflammation, and Severe Asthma: an Update Among adults diagnosed with asthma, higher body mass index is also linked to faster lung function decline.14European Respiratory Journal. Predictors of accelerated decline in lung function in adult-onset asthma
Hormonal factors clearly play a role, though the research has produced some conflicting findings. An older prospective study of U.S. nurses found that postmenopausal women who had never used hormone replacement therapy had a lower risk of asthma than premenopausal women, while those who used postmenopausal hormones, particularly estrogen alone, had a higher risk. Women who used hormones for ten or more years had about twice the risk.15PubMed. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study A French cohort study also found that estrogen-only hormone therapy raised asthma risk, particularly in never-smokers and women with prior allergies.16Thorax. Postmenopausal hormone therapy and asthma onset in the E3N cohort
However, a large national cohort study of over a million person-years of follow-up found the opposite pattern: both current and past use of hormone replacement therapy was associated with a reduced risk of asthma onset, and longer use appeared even more protective.17PubMed. Hormone replacement therapy and asthma onset in menopausal women: National cohort study The disagreement likely reflects differences in study populations, time periods, and the types of hormone preparations used. What is clear is that sex hormones influence asthma risk in ways that are complex and still being sorted out.
Psychological stress is another underappreciated risk factor. A Danish longitudinal study found that people reporting high perceived stress had roughly double the risk of developing asthma and being hospitalized for it compared to those with low stress.18PubMed. Perceived stress and risk of adult-onset asthma and other atopic disorders: a longitudinal cohort study Adverse childhood experiences also appear to cast a long shadow: adults who experienced multiple forms of childhood adversity had about a 31% higher risk of developing asthma later in life, with the effect partly channeled through adult risk factors like financial stress, smoking, and obesity.19PubMed. Multiple adverse childhood experiences and asthma onset in adulthood: Role of adulthood risk factors as mediators
Workplace and Air Pollution Triggers
Occupational asthma is one of the most preventable forms of adult-onset asthma, yet it remains underdiagnosed. It develops after a latency period of exposure to sensitizing agents in the workplace, which can include biological compounds like flour dust, animal proteins, and latex, as well as low-molecular-weight chemicals like isocyanates (used in paints and plastics) and certain cleaning products.20PubMed. Mechanisms of occupational asthma A separate pattern involves high-level exposure to irritants that can trigger asthma symptoms without the immune sensitization process, sometimes called reactive airways dysfunction syndrome.21PubMed. Occupational asthma: current concepts in pathogenesis, diagnosis, and management Workers in baking, healthcare, cleaning, manufacturing, and agriculture are at elevated risk.
Outdoor air pollution also contributes. A systematic review and meta-analysis found that for every 5 μg/m³ increase in fine particulate matter (PM2.5), the risk of developing adult asthma rose by about 7%, and for every 10 μg/m³ increase in nitrogen dioxide, the risk rose by about 11%.22The Lancet Respiratory Medicine. Association between ambient air pollutants and risk of incident adult asthma: a systematic review and meta-analysis A large study of U.S. women also linked PM2.5 exposure to increased asthma risk.23American Journal of Respiratory and Critical Care Medicine. Ambient Air Pollution Exposure and Incident Adult Asthma in a Nationwide Cohort of U.S. Women Living near busy roads or in areas with poor air quality is a genuine contributor to new adult asthma cases.
Respiratory infections can also tip someone into asthma for the first time. COVID-19 has brought renewed attention to this pathway: SARS-CoV-2 can damage the airway lining, trigger chronic inflammation, and push the immune system toward the type of response that underlies asthma.24Meditsinskiy sovet = Medical Council. Post-COVID-19 as a risk factor for development and progression of bronchial asthma It is too early to know the full long-term impact, but post-COVID respiratory symptoms that persist for months should prompt evaluation for possible new-onset asthma.
Why Diagnosis Can Be Tricky
Getting a correct diagnosis of adult-onset asthma is harder than it sounds, because two other conditions commonly mimic or overlap with it. The first is COPD, the umbrella term for chronic bronchitis and emphysema. Both COPD and adult-onset asthma cause coughing, wheezing, and shortness of breath in middle-aged and older adults. Traditional distinguishing features like age of onset, how much airway narrowing reverses with a bronchodilator, and whether the patient has allergies all overlap between the two conditions, which leads to frequent misdiagnosis.25PubMed Central. Distinguishing adult-onset asthma from COPD: a review and a new approach Some patients have features of both, a condition sometimes called asthma-COPD overlap, which complicates treatment decisions further.
The second mimic is vocal cord dysfunction, where the vocal cords inappropriately close during breathing and cause wheezing and breathlessness that look and sound like asthma. Key clues that point toward vocal cord dysfunction include wheezing that happens mainly during breathing in rather than out, symptoms that resolve quickly, and poor response to standard asthma medications.26PubMed Central. Differentiating vocal cord dysfunction from asthma If you have been treated for asthma but your inhalers never seem to help, this is worth raising with your doctor.
Treatment Challenges and Biologics
First-line treatment for asthma, at any age, is inhaled corticosteroids, often combined with long-acting bronchodilators. For many adults with eosinophilic or allergic asthma, this works well. The problem is that a large share of adult-onset asthma is non-eosinophilic, and inhaled corticosteroids are much less effective against those subtypes. This is a major reason why adult-onset asthma is more often classified as difficult to control.
For severe asthma that does not respond adequately to standard inhalers, biologic therapies have transformed the landscape over the past decade. These are injectable medications that target specific molecules in the inflammatory cascade. Current options include drugs targeting IgE, interleukin-5, the interleukin-5 receptor, interleukin-4/interleukin-13, and a molecule called thymic stromal lymphopoietin (TSLP).27PubMed Central. Biologic Therapies for Severe Asthma: Current Insights and Future Directions These biologics reduce flare-ups, cut down on hospitalizations, and can often eliminate or sharply reduce the need for oral steroids, which carry serious long-term side effects like bone loss and diabetes.28European Respiratory Review. Biologics in severe asthma: a state-of-the-art review
Choosing the right biologic depends on which inflammatory pathway is driving a person’s asthma, which is where blood tests and exhaled nitric oxide measurements come in. Identifying the correct subtype through these biomarkers is increasingly seen as essential to getting the treatment right. Adults whose asthma is genuinely non-eosinophilic and non-allergic have fewer biologic options, though tezepelumab, which targets TSLP upstream of the eosinophil pathway, shows promise for a broader range of asthma subtypes.
Long-Term Outlook and Remission
One of the hardest things to hear about adult-onset asthma is that remission is uncommon. A Finnish study following patients for 12 years found that only about 3% achieved remission. Roughly a third had controlled asthma, another third was partially controlled, and nearly a third remained uncontrolled.29PubMed. A 12-year prognosis of adult-onset asthma: Seinäjoki Adult Asthma Study A Dutch study of about five years of follow-up was slightly more optimistic, finding roughly 16% achieved clinical remission. But the predictors of remission were telling: patients who went into remission tended to have milder disease at the start, better asthma control, and no nasal polyps. Those with nasal polyps and more severe airway hyperresponsiveness at the time of diagnosis had less than a 1% chance of remission within five years.30Journal of Allergy and Clinical Immunology. Clinical predictors of remission and persistence of adult-onset asthma
Persistent airway inflammation, repeated flare-ups, and progressive structural changes in the airways all contribute to lung function that trends downward over time, especially in severe cases.31The Journal of Allergy and Clinical Immunology: In Practice. Lung Function Decline in Asthma: Mechanisms, Risk Factors, and Clinical Implications for Personalized Management The factors most strongly linked to faster lung function decline in adult-onset asthma include high exhaled nitric oxide levels and low BMI, which might seem counterintuitive given that obesity is a risk factor for developing asthma in the first place. One study found the fastest decline in patients who had both elevated exhaled nitric oxide and low BMI.32European Respiratory Journal. Predictors of accelerated decline in lung function in adult-onset asthma The explanation may be that low-BMI patients with high eosinophilic inflammation represent a distinct and particularly aggressive phenotype.
Among patients with persistent asthma at the 15-year mark, those with uncontrolled disease tended to have higher blood neutrophil levels.33PubMed Central. Remission of adult-onset asthma is rare: a 15-year follow-up study This reinforces the theme that neutrophilic inflammation, which is resistant to standard inhaled steroids, is one of the defining challenges of adult-onset asthma management.
Conditions That Travel With Adult-Onset Asthma
Adult-onset asthma rarely shows up alone. Chronic rhinosinusitis, the persistent inflammation of the sinuses, co-occurs with asthma at high rates. Roughly 22% to 45% of people with asthma also have chronic rhinosinusitis, and having both conditions is linked to worse asthma symptoms.34Allergy Medicine. Chronic rhinosinusitis, asthma, and gastroesophageal reflux: Epidemiology, pathophysiology, and comorbidity When gastroesophageal reflux disease (GERD) enters the picture alongside chronic rhinosinusitis, the odds of having asthma jump even higher.35Annals of Allergy, Asthma & Immunology. Prevalence of allergic rhinitis and asthma in patients with chronic rhinosinusitis and gastroesophageal reflux disease All three conditions involve mucosal inflammation in connected parts of the airway and digestive tract, and treating one without addressing the others often leads to incomplete symptom control.
Nasal polyps deserve special mention. They appeared repeatedly in the research as both a marker of severe eosinophilic adult-onset asthma and a predictor of worse outcomes. A related condition called aspirin-exacerbated respiratory disease involves asthma, nasal polyps, and severe sinus disease triggered by aspirin and similar anti-inflammatory drugs. All patients with this condition have underlying nasal polyps and chronic sinus problems that can be stubbornly difficult to treat.36PubMed Central. Aspirin-exacerbated respiratory disease: evaluation and management If you develop asthma as an adult and also have nasal polyps or chronic sinus trouble, that combination should prompt a thorough workup for this specific syndrome.
The Airway Microbiome and Emerging Research
One of the newer areas of investigation involves the community of bacteria living in the airways. In healthy lungs, there is a diverse mix of microbes. In adults with poorly controlled asthma, that community is often disrupted, with an overgrowth of certain bacterial groups that correlates with more frequent flare-ups and resistance to steroids.37PubMed. Environmental factors influencing the microbiome in adult asthma: emerging mechanistic insights Whether this microbial imbalance causes the steroid resistance or is simply a marker of it is still being worked out. Early research suggests that environmental factors like diet, antibiotics, and pollution can shift the airway microbiome toward these unfavorable patterns, opening up the possibility that restoring a healthy microbial balance could eventually become part of asthma treatment. That is still speculative, but it reflects a broader shift in thinking about asthma as a condition shaped not just by your immune system and your genes, but also by the microbial ecosystem you carry around with you.
On the genetic front, pharmacogenomic research has begun identifying gene variants that predict how well a person will respond to specific asthma medications. For example, certain variants in the CRHR1 gene have been linked to a significantly higher risk of exacerbations while on inhaled corticosteroids, while a variant in TBXT is associated with a better response to those same drugs.38PubMed. Pharmacogenetics of inhaled corticosteroids and exacerbation risk in adults with asthma Similar work has explored genetic variation in responses to bronchodilators and leukotriene modifiers.39PubMed. Asthma Pharmacogenomics: 2015 Update Genetic testing for asthma drug response is not part of routine clinical care yet, but it represents a plausible future step toward matching adult-onset asthma patients with the therapies most likely to work for them, rather than cycling through months or years of trial and error.